You determine how to heal gut inflammation in your unique circumstances
Accordingly, distinguishing sensory, hedonic, and motivational phenotypes may improve interpretation of both patient-reported outcomes and mechanistic studies ( 7.3 Temporal dynamics and adaptation The interpretation of altered eating experience during GLP-1RA treatment is also likely to depend on time course (70)
Full study data are available on request
Further investigations revealed that AM1241, a selective cannabinoid receptor type 2 (CB2) agonist, can inhibit pro-inflammatory polarization of microglia and reduce NLRP3-mediated neuroinflammation, thereby attenuating seizure frequency and alleviating depressive symptoms
Bottom line: The better question may not be, Did the patient stop? It may be, Did we help the patient stay on the treatment journey, even if the molecule changed? #ObesityMedicine #GLP1 #Semaglutide #Tirzepatide #WeightManagement #MetabolicHealth #RealWorldEvidence #Endocrinology Very interesting, can you share the link to the study
The needle hub locks to the syringe tip with a push and a twist
